# UNIVERSITY OF TX MD ANDERSON CAN CTR: Multi-omic liquid biopsy assessment in NCI trials: evaluating ctDNA, extravesicle RNA, and outcomes with immunotherapy in patient with colorectal and anal cancers

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF TX MD ANDERSON CAN CTR |
| Location | HOUSTON, TX |
| Project | Multi-omic liquid biopsy assessment in NCI trials: evaluating ctDNA, extravesicle RNA, and outcomes with immunotherapy in patient with colorectal and anal cancers |
| Project number | 5R50CA285403-03 |
| Mechanism | R50 |
| Institute | National Cancer Institute |
| Award | $181,640 |
| Awarded | 2026-08-27 |
| Project period | 2024-09-12 to 2029-08-31 |
| UEI | S3GMKS8ELA16 |

## Why this score
- Award of $181,640.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11415692). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.